PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis

PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis

Han Li,1,* Ke Su,1,* Lu Guo,2,* Yi Jiang,1 Ke Xu,1 Tao Gu,1 Jiali Chen,1 Zhenying Wu,1 Pan Wang,3 Xi Zhang,4 Yushan Yan,1 Siyuan Li,1 Xue Wu,1 Lei Han,5 Kun He,6 Lianbin Wen,7 Bo Li,4 Yunwei Han1 1Department of Oncology, The Affiliated Hospital of Southwest Medical University...

Full description

Bibliographic Details
Main Authors: Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hcc
pd-1 inhibitors
antiangiogenic therapy;tace
Online Access:https://www.dovepress.com/pd-1-inhibitors-combined-with-antiangiogenic-therapy-with-or-without-t-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/pd-1-inhibitors-combined-with-antiangiogenic-therapy-with-or-without-t-peer-reviewed-fulltext-article-JHC

Similar Items